Immuno Therapy /
NGS Biomarkers / Pathways
Pharmaceutical / Clinical Trials
BVP contracted to produce 3-D imagery for the phase 3 clinical trial evaluating the use of edifoliglide (E2F Decoy), an investigational product to prevent vein graft failure following coronary artery bypass graft surgery (CABG).
Additionally, Avastin, the cancer fighting drug, and Next Generation Sequences immunotherapies were produced with 3-D visuals.